Your session is about to expire
← Back to Search
Time-Restricted Eating vs. Calorie Restriction for Weight Loss and Colorectal Cancer Risk Reduction
Study Summary
This trial will show that time-restricted eating, a type of intermittent fasting, is an effective way to help obese people lose weight and prevent colorectal cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of serious health issues like kidney disease, autoimmune disorders, or severe heart and lung conditions.I am between 45 and 65 years old with a BMI between 30 and 49.99.I have been treated for cancer or have a genetic risk for colorectal cancer in the last year.I am not on any weight loss medications.I am at high risk for colorectal cancer due to having 3 or more polyps or a large polyp in the last 5 years.I am perimenopausal or have an irregular menstrual cycle.I am between 45 and 70 years old.I am currently on blood thinners or medications that increase bleeding risk.I am currently on antiviral or immunosuppressant medications.My diabetes is under control, or I might have undiagnosed diabetes with HbA1c over 9%.You have been up to date with CRC screening.You have prediabetes or insulin resistance.
- Group 1: Control
- Group 2: Time Restricted Eating (TRE)
- Group 3: Calorie Restriction (Cal-R)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there still space available for participants of this research?
"Confirmed, this trial is still accepting participants. On May 17th 2022, the study was first posted and its contents last revised on August 22nd 2022."
Does this research involve any geriatric individuals?
"To qualify for this trial, individuals must be between the ages of 45-65."
What is the overall size of the population involved in this clinical trial?
"Affirmative. The clinicaltrials.gov platform reveals that enrollment for this trial opened on May 17th 2022 and is still ongoing, as the study was most recently updated on August 22nd of the same year. 255 patients are planned to be recruited from a single site."
For whom is this scientific research appropriate?
"To qualify for this trial, potential participants must have a BMI above the normal range and fall between 45-65 years of age. This medical experiment is hoping to enroll 255 patients in total."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Illinois at Chicago: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger